End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.03 CNY | +1.20% | +5.18% | +9.49% |
Apr. 23 | Cisen Pharmaceutical Names Chief Financial Officer | MT |
Apr. 22 | Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 3,402
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small Volume Injection
29.2
%
| 1,006 | 24.7 % | 1,301 | 29.2 % | +29.31% |
Large Infusion - Plastic Bottles
23.6
%
| 850 | 20.9 % | 1,053 | 23.6 % | +23.98% |
Large Infusion - Non-PVC Soft Bag
16.8
%
| 756 | 18.6 % | 749 | 16.8 % | -0.97% |
Oral Solid Dosage
10.7
%
| 470 | 11.6 % | 479 | 10.7 % | +1.82% |
Large Infusion - Glass Bottle
6.2
%
| 368 | 9.0 % | 277 | 6.2 % | -24.70% |
Ointment
4.2
%
| 186 | 4.6 % | 189 | 4.2 % | +1.56% |
Freeze-Dried Powder Injection
4.2
%
| 152 | 3.7 % | 186 | 4.2 % | +22.33% |
Drops
3.6
%
| 151 | 3.7 % | 160 | 3.6 % | +5.76% |
Original Ingredients
0.8
%
| 91 | 2.2 % | 37 | 0.8 % | -59.16% |
Flushing Agent
0.5
%
| 20 | 0.5 % | 21 | 0.5 % | +6.24% |
Others
0.2
%
| 1 | 0.0 % | 11 | 0.2 % | +1,927.84% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.3
%
| 4,005 | 98.9 % | 4,419 | 99.3 % | +10.34% |
Foreign
0.7
%
| 44 | 1.1 % | 32 | 0.7 % | -27.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 98-11-05 |
En Long Zhao
CHM | Chairman | 45 | 04-06-30 |
Xin Bang Xu
DFI | Director of Finance/CFO | 46 | 00-07-31 |
Xiang Liu
BRD | Director/Board Member | 35 | 17-06-30 |
Yan Liu
BRD | Director/Board Member | 39 | 10-06-30 |
Xiu Lian Lu
BRD | Director/Board Member | 57 | 98-11-05 |
Liu Shan Hao
BRD | Director/Board Member | 54 | 98-11-05 |
Wei Sun
IRC | Investor Relations Contact | 42 | 20-12-07 |
Xiang Lin Zhang
PRN | Corporate Officer/Principal | 54 | 98-11-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Zhang
BRD | Director/Board Member | 59 | 17-11-27 |
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 98-11-05 |
Hong Cai
BRD | Director/Board Member | 63 | 20-12-07 |
Xin Sheng Sun
BRD | Director/Board Member | 71 | 17-11-27 |
Liu Shan Hao
BRD | Director/Board Member | 54 | 98-11-05 |
Xiu Lian Lu
BRD | Director/Board Member | 57 | 98-11-05 |
Xiang Lin Zhang
PRN | Corporate Officer/Principal | 54 | 98-11-05 |
Xin Bang Xu
DFI | Director of Finance/CFO | 46 | 00-07-31 |
Peng Mei Tian
BRD | Director/Board Member | 44 | 21-10-24 |
Xiang Liu
BRD | Director/Board Member | 35 | 17-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 452,775,129 | 171,062,138 ( 37.78 %) | 10,500 ( 0.002319 %) | 37.78 % |
Company contact information
Cisen Pharmaceutical Ltd.
16, Tongji Road High-tech Zone
272073, Jining
+86 53 7298 9199
http://www.lkcisen.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+9.49% | 1B | |
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+12.33% | 13.54B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B |
- Stock Market
- Equities
- 603367 Stock
- Company Cisen Pharmaceutical Co., Ltd.